Interparfums (IPAR) Competitors

Interparfums has lower revenue, but higher earnings than Coty. Coty is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

42.4% of Coty shares are owned by institutional investors. Comparatively, 55.6% of Interparfums shares are owned by institutional investors. 5.9% of Coty shares are owned by company insiders. Comparatively, 43.6% of Interparfums shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Interparfums has a net margin of 11.17% compared to Coty's net margin of -10.42%. Interparfums' return on equity of 15.21% beat Coty's return on equity.

Coty presently has a consensus price target of $3.24, indicating a potential upside of 20.70%. Interparfums has a consensus price target of $123.29, indicating a potential upside of 7.12%. Given Coty's higher probable upside, equities analysts clearly believe Coty is more favorable than Interparfums.

In the previous week, Interparfums had 8 more articles in the media than Coty. MarketBeat recorded 8 mentions for Interparfums and 0 mentions for Coty. Interparfums' average media sentiment score of 0.79 beat Coty's score of 0.50 indicating that Interparfums is being referred to more favorably in the news media.

Coty has a beta of 0.95, meaning that its stock price is 5% less volatile than the broader market. Comparatively, Interparfums has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market.

92.4% of e.l.f. Beauty shares are held by institutional investors. Comparatively, 55.6% of Interparfums shares are held by institutional investors. 3.5% of e.l.f. Beauty shares are held by insiders. Comparatively, 43.6% of Interparfums shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

e.l.f. Beauty has a beta of 1.6, suggesting that its stock price is 60% more volatile than the broader market. Comparatively, Interparfums has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market.

Interparfums has lower revenue, but higher earnings than e.l.f. Beauty. Interparfums is trading at a lower price-to-earnings ratio than e.l.f. Beauty, indicating that it is currently the more affordable of the two stocks.

e.l.f. Beauty presently has a consensus target price of $97.13, suggesting a potential downside of 4.40%. Interparfums has a consensus target price of $123.29, suggesting a potential upside of 7.12%. Given Interparfums' higher possible upside, analysts plainly believe Interparfums is more favorable than e.l.f. Beauty.

Interparfums has a net margin of 11.17% compared to e.l.f. Beauty's net margin of 3.38%. Interparfums' return on equity of 15.21% beat e.l.f. Beauty's return on equity.

In the previous week, Interparfums had 1 more articles in the media than e.l.f. Beauty. MarketBeat recorded 8 mentions for Interparfums and 7 mentions for e.l.f. Beauty. e.l.f. Beauty's average media sentiment score of 1.07 beat Interparfums' score of 0.79 indicating that e.l.f. Beauty is being referred to more favorably in the media.

Interparfums pays an annual dividend of $3.20 per share and has a dividend yield of 2.8%. Lamb Weston pays an annual dividend of $1.52 per share and has a dividend yield of 3.5%. Interparfums pays out 61.2% of its earnings in the form of a dividend. Lamb Weston pays out 73.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Interparfums has increased its dividend for 4 consecutive years and Lamb Weston has increased its dividend for 7 consecutive years. Lamb Weston is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Interparfums currently has a consensus price target of $123.29, suggesting a potential upside of 7.12%. Lamb Weston has a consensus price target of $52.91, suggesting a potential upside of 22.24%. Given Lamb Weston's higher probable upside, analysts plainly believe Lamb Weston is more favorable than Interparfums.

Interparfums has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market. Comparatively, Lamb Weston has a beta of 0.47, suggesting that its stock price is 53% less volatile than the broader market.

In the previous week, Lamb Weston had 4 more articles in the media than Interparfums. MarketBeat recorded 12 mentions for Lamb Weston and 8 mentions for Interparfums. Interparfums' average media sentiment score of 0.79 beat Lamb Weston's score of 0.46 indicating that Interparfums is being referred to more favorably in the media.

Interparfums has a net margin of 11.17% compared to Lamb Weston's net margin of 4.39%. Lamb Weston's return on equity of 23.33% beat Interparfums' return on equity.

55.6% of Interparfums shares are held by institutional investors. Comparatively, 89.6% of Lamb Weston shares are held by institutional investors. 43.6% of Interparfums shares are held by insiders. Comparatively, 1.0% of Lamb Weston shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Lamb Weston has higher revenue and earnings than Interparfums. Lamb Weston is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

In the previous week, Interparfums had 4 more articles in the media than Medifast. MarketBeat recorded 8 mentions for Interparfums and 4 mentions for Medifast. Interparfums' average media sentiment score of 0.79 beat Medifast's score of 0.51 indicating that Interparfums is being referred to more favorably in the news media.

Medifast has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market. Comparatively, Interparfums has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market.

Interparfums has a net margin of 11.17% compared to Medifast's net margin of -8.08%. Interparfums' return on equity of 15.21% beat Medifast's return on equity.

Medifast presently has a consensus target price of $12.00, indicating a potential upside of 3.12%. Interparfums has a consensus target price of $123.29, indicating a potential upside of 7.12%. Given Interparfums' stronger consensus rating and higher possible upside, analysts clearly believe Interparfums is more favorable than Medifast.

Interparfums has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

95.5% of Medifast shares are held by institutional investors. Comparatively, 55.6% of Interparfums shares are held by institutional investors. 3.7% of Medifast shares are held by company insiders. Comparatively, 43.6% of Interparfums shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.